Zydus gets USFDA nod for generic acne treatment drug
The drug firm has received final approval from the US Food and Drug Administration (USFDA) for Isotretinoin Capsules USP (10 mg, 20 mg 30 mg and 40 mg), it said in a statement.
Shares of Zydus Lifesciences were trading 0.13 per cent down at Rs 627.35 apiece on the BSE.(Image credit:File photo)